Latest News
Conference Coverage
Fetal MRI may change pregnancy management
Charlotte, N.C. – For about two-thirds of patients, fetal MRI changed or clarified the diagnosis that had resulted...
Conference Coverage
CMT1A neuropathy improves with investigational drug PXT3003
AUSTIN, TEX. – Adverse events during treatment were similar across intervention and placebo groups, with similar rates of trial attrition.
Conference Coverage
Edasalonexent may slow progression of Duchenne muscular dystrophy
CHARLOTTE, N.C. – Functional measures and disease biomarkers stabilized when patients received the investigational NF-kB inhibitor.
Conference Coverage
Blood test might rival PET scan for detecting brain amyloidosis
ST. LOUIS – A blood test that measures the plasma ratio of amyloid-beta 42 peptide to amyloid-beta peptide 40 can accurately screen cognitively...
Conference Coverage
Baricitinib may benefit patients with Aicardi-Goutières syndrome
CHARLOTTE, N.C. – A compassionate use trial indicates that JAK inhibition may have a role in the treatment of genetic interferonopathies.
Conference Coverage
Celiac disease may underlie seizures
CHARLOTTE, N.C. – A gluten-free diet may reduce seizure burden in children with celiac disease and intractable seizures, a retrospective chart...
Latest News
Pediatric epilepsy surgery may improve cognition and behavior
CHARLOTTE, NC – Comorbidities may influence the likelihood of perceived improvement, whereas the type of surgery may not.
Conference Coverage
Delay in EEG monitoring associated with increased seizure duration in pediatric refractory status epilepticus
Charlotte, NC – The 24-hour cumulative probability of seizure resolution may be lower in children who do not have...
Conference Coverage
Does AED prophylaxis delay seizure onset in children with brain tumors?
CHARLOTTE, N.C. – A small study indicates that AED prophylaxis may be effective during the first 6 months after...
Feature
Dr. Paul Aisen Q&A: Aducanumab for Alzheimer’s
A leading Alzheimer’s researcher, Dr. Aisen answers some questions about the resurrection of aducanumab as a potential therapy for Alzheimer’s...
From the Journals
Demeaning patient behavior takes emotional toll on physicians
Deciding how or whether to respond was often dictated by the level of support from colleagues, a professional responsibility to peers.